Population Health Alliance Welcomes Eyenuk as Its Newest Member

WASHINGTON, March 10, 2022 /PRNewswire-PRWeb/ -- Population Health Alliance (PHA), the industry's only multi-stakeholder professional and trade association solely focused on population health, announced today that Eyenuk, Inc. has joined the organization as its newest member. Eyenuk is a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™ and AI Predictive Biomarkers™. Eyenuk's EyeArt® AI system is the only FDA-cleared autonomous AI technology for detection of both more than mild and vision-threatening diabetic retinopathy.

"Population health professionals are increasingly aware of the tremendous clinical and economic value that autonomous AI technologies can bring to their organizations and patients they serve through early detection," said Rose Maljanian, Chairman Emeritus of PHA and Chairman & CEO of HealthCAWS. "PHA is excited about the important contribution Eyenuk can make to the population health community by bringing its technological innovation to prevent worsening complications in high-volume, high-risk conditions such as diabetes," she added.

"With its potential to improve health equity and access, reduce diagnostic bias, and enable instant disease detection results at point-of-care settings, our FDA-cleared and Medicare-reimbursed EyeArt autonomous AI system is well positioned to deliver significant clinical and economic improvements to diabetes care and population health," said Kaushal Solanki, PhD, founder and CEO of Eyenuk.

Eyenuk will be featured during the next PHA Member Showcase Webinar set for Wednesday, March 30, 2022, at 2:00pm ET. During this one-hour webinar, "Embracing Population Health Technological Innovations for Diabetes Management," Christy Mokrohisky, Vice President for Population Health at Providence St. Joseph Health, will join Frank Cheng, Eyenuk's President and CCO, as the keynote speakers. Registration for this free webinar, open to all population health management professionals, is available at http://ow.ly/AL4W50Ic7zG.

###

ABOUT PHA
Established in 1998, Population Health Alliance (PHA) is the industry's only multi-stakeholder professional and trade association solely focused on population health management, representing stakeholders (e.g, health systems, health plans, employer solutions, academia, biopharma and technology companies) from across the health care ecosystem that seek to improve health outcomes optimize the consumer and provider experience and drive affordability. http://www.populationhealthalliance.org | @PHAVoice

ABOUT Eyenuk, Inc.
Eyenuk, Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening™ for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk, and Alzheimer's disease. Find Eyenuk online on its website, Twitter, Facebook, and LinkedIn.

Media Contact

Karen Seidman, Population Health Alliance, 1 202-364-8134, [email protected]

Frank Cheng, Eyenuk, 818-835-3585, [email protected]

SOURCE Population Health Alliance